Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
ESG stocks
Momentum stocks
Growth stocks
Undervalued stocks
Trend-Following Stocks
Yield stocks
Investment Themes
Strategic Metals
Biotechnology
In Vino Veritas
Ageing Population
Cybersecurity
Robotics
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
Smart City
Let's all cycle!
Ageing Population
The future of mobility
Sin stocks
In Vino Veritas
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
United States
Nasdaq
Anika Therapeutics, Inc.
News
Summary
ANIK
US0352551081
ANIKA THERAPEUTICS, INC.
(ANIK)
Add to my list
Report
Real-time Estimate Cboe BZX -
01:35 2022-06-27 pm EDT
23.09
USD
+2.49%
06/10
ANIKA THERAPEUTICS, INC.
: Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
06/10
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
GL
06/10
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
GL
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
Sector Update: Health Care
05/20/2022 | 08:49am EDT
Send by mail :
Name :
First name :
From
*
:
To
*
:
(You can enter multiple email addresses separated by commas)
Message :
*
Required fields
© MT Newswires 2022
Stocks mentioned in the article
Change
Last
1st jan.
ANIKA THERAPEUTICS, INC.
2.70%
23.1393
-37.12%
NASDAQ COMPOSITE
-0.58%
11541.52
-25.81%
All news about ANIKA THERAPEUTICS, INC.
06/10
ANIKA THERAPEUTICS, INC.
: Change in Directors or Principal Officers, Submission of Matter..
AQ
06/10
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
GL
06/10
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
GL
05/20
SECTOR UPDATE
: Health Care Stocks Gain Premarket Friday
MT
05/20
SECTOR UPDATE
: Health Care
MT
05/20
Anika Therapeutics Says FDA Approves X-Twist System for Soft Tissue Repair
MT
05/20
Anika Receives FDA 510(k) Clearance for the X-Twist™ Knotless Fixation System, Ex..
GL
05/20
Anika Receives FDA 510(k) Clearance for the X-Twist Knotless Fixation System, Expanding..
CI
05/20
Anika Therapeutics Gets FDA OK for X-Twist Knotless Fixation System
DJ
05/13
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
More news
Analyst Recommendations on ANIKA THERAPEUTICS, INC.
03/09
Stephens Downgrades Anika Therapeutics to Equalweight from Overweight, Adjusts Price Ta..
MT
2021
Stephens Starts Anika Therapeutics at Overweight With $55 Price Target
MT
2021
Barrington Adjusts Price Target on Anika Therapeutics to $48 From $44, Keeps Outperform..
MT
More recommendations
Financials (USD)
Sales 2022
154 M
-
-
Net income 2022
-11,0 M
-
-
Net Debt 2022
-
-
-
P/E ratio 2022
-29,8x
Yield 2022
-
Capitalization
328 M
328 M
-
Capi. / Sales 2022
2,12x
Capi. / Sales 2023
1,93x
Nbr of Employees
297
Free-Float
98,1%
More Financials
Chart ANIKA THERAPEUTICS, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Full-screen chart
Technical analysis trends ANIKA THERAPEUTICS, INC.
Short Term
Mid-Term
Long Term
Trends
Bullish
Bearish
Bearish
Technical analysis
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
More Financials
Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
22,53 $
Average target price
37,50 $
Spread / Average Target
66,4%
Consensus
EPS Revisions
Please enable JavaScript in your browser's settings to use dynamic charts.
More Estimates Revisions
Managers and Directors
Cheryl Renee Blanchard
President, Chief Executive Officer & Director
Michael L. Levitz
Chief Financial Officer, Treasurer & EVP
Jeffery S. Thompson
Chairman
Mira Leiwant
VP-Quality, Regulatory & Clinical Affairs
Steven W. Ek
Vice President-Research & Development
More about the company
Sector and Competitors
1st jan.
Capi. (M$)
ANIKA THERAPEUTICS, INC.
-37.12%
328
CSL LIMITED
-6.70%
90 814
SAMSUNG BIOLOGICS CO.,LTD.
-7.97%
45 825
WUXI BIOLOGICS (CAYMAN) INC.
-16.59%
41 498
BIOGEN INC.
-11.67%
31 038
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
-19.19%
24 084
More Results
Slave